Amakuru y'ikigo
Uburyo bwo kuvura bwa BIOOCUS Medical Group Dual CD19/BCMA CAR-T butanga umusaruro mwiza mu ndwara ya Refractory Myasthenia Gravis: Urugendo rw'umurwayi ukiri muto
Iterambere mu by'amasomo | Itsinda ry'abaganga rya Lu Daopei ryasohoye ubushakashatsi butangaje mu kinyamakuru cy'ubwongereza cy'ubuvuzi bw'amaraso
Itsinda ry’abaganga rya Lu Daopei, riyobowe na Dr. Cao Xingyu na Prof. Lu Peihua, ryasohoye inyandiko y’ingenzi y’ubushakashatsi ku buvuzi muri Ikinyamakuru cy'Ubwongereza cy'Ubumenyi bw'amaraso (Ingaruka 5.1). Ubushakashatsi bugamije gusuzuma umutekano n'ubushobozi bwo gutera uturemangingo tw'amaraso mu maraso (allo-HSCT) nyuma yo kuvura CD7 CAR-T ku buryo bwo kuvura kanseri y'amaraso mu maraso ya T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (R/R T-ALL/T-LBL) idashobora kugaragara.
Ubushakashatsi bwakozwe mu bigo byinshi bwerekanye ko hari ingaruka nziza ku barwayi ba kanseri y'amaraso barimo guterwa MTUD Allogeneic Stem Cell Transplantation na ATG
Ubushakashatsi bunini bwakorewe mu Bushinwa mu bigo byinshi bwagaragaje ibisubizo byiza ku barwayi bafite kanseri y’amaraso baterwa uturemangingo tw’umubiri tudahuye (MMUD) hamwe na ATG mu rwego rwo kwirinda GVHD.
Inkuru y'umurwayi: B-ALL ifite ibyago byinshi, guterwa igufwa ry'umusemburo w'amagufwa ku mezi 9, imyaka ibiri nyuma yaho—Intangiriro nziza ku murwanyi ukiri muto
Umwana w'amezi 9, wasanzwemo indwara ya kanseri y'amaraso ya B-ALL (Acute B Lymphoblastic Leukemia) iri mu kaga gakomeye, yatewe umworera w'amagufwa neza. Nyuma y'imyaka ibiri, umwana arimo gukura neza kandi yiteguye kujya mu ishuri ry'incuke.
Gusobanukirwa Thalassemia: Ubuyobozi Burambuye ku Miterere ya Alpha na Beta
Thalassemia ni indwara zirenze imwe. Iyi nyandiko isuzuma indwara ya alpha na beta thalassemia, impamvu zayo, ibimenyetso byayo, ndetse n'uburyo bushya bwo kuvura buboneka muri BIOOCUS International Medical Center.
Dr. Lu Peihua yatanze ikiganiro ku iterambere mu buvuzi bwa CAR-T mu nama ngarukamwaka ya 29 ya APBMT
Mu nama ngarukamwaka ya 29 yo gutera amaraso no gutera utwo turemangingo (APBMT) muri Aziya na Pasifika, Dr. Lu Peihua yatanze ikiganiro cy’ingenzi ku ntsinzi y’ubuvuzi bwa CAR-T mu Bushinwa. Amakuru y’itsinda rye aturuka mu buvuzi yashimiwe ku rwego mpuzamahanga, agaragaza uruhare rwabo mu kuvura kanseri y’amaraso.
ASH 2024: Itsinda rya Lu Daopei ryerekanye ibyagezweho mu bushakashatsi 13 mu bijyanye n'amaraso
Mu nama iteganyijwe ya ASH 2024, itsinda ry’abaganga bo mu bitaro bya Lu Daopei rizagaragaza ibyavuye mu bushakashatsi 13 bw’ingenzi, bigaragaza iterambere mu bijyanye n’amaraso n’ubushobozi bwo kuvura CAR-T, bongera kwemeza ko bashyizeho umwete mu kunoza umusaruro w’abarwayi.
Kurwanya Lymphoma hakoreshejwe uburyo bubiri bwo kuvura CAR-T
Nyuma yo kumara imyaka itatu arwaye kanseri y’urubogobogo, umugore w’imyaka 61 yakize burundu binyuze mu buvuzi bushya bwa CAR-T muri BIOOCUS, agaragaza ubushobozi bwo kuvura kanseri mu buryo buhanitse.
Bioocus yitabiriye IGC 2024 kugira ngo ishakishe ubufatanye bushya n'uburyo bushya bw'ubucuruzi mu buvuzi bw'imyororokere n'uturemangingo
Bioocus yishimiye kwinjira mu nama ya 8 y’ubuvuzi bw’uturemangingo n’uturemangingo (IGC 2024)! Twiteguye gukorana n’inzobere ku isi no gushakisha uburyo bushya bw’ubucuruzi bujyanye n’ikoranabuhanga rigezweho ryo kuvura uturemangingo n’uturemangingo. Twese hamwe, reka dushyireho ejo hazaza ho kuvura ubudahangarwa bw’umubiri.
Ingufu nyinshi zo kuvura CD7 CAR-T ku ndwara za B-cell: Iterambere mu kuvura kanseri
Ubushakashatsi buheruka bwerekana akamaro n'umutekano wa CD7 CAR-T selile mu kuvura kanseri y'amaraso ya B-cell acute lymphoblastic leukemia (B-ALL) yasubiwemo cyangwa itarakira na T-cell lymphoblastic lymphoma (T-LBL). Ubu bushakashatsi bwakozwe na BIOOCUS ku bufatanye n'ibitaro bya Lu Daopei, bugaragaza umusaruro mwiza ku barwayi, butanga ubundi buryo bukomeye bwo kuvura kanseri busanzwe.
Ingufu z'igihe kirekire zo kuvura CD19 CAR T-cells mu kuvura Leukemia yo mu bwoko bwa Acute Lymphoblastic Leukemia yasubiwemo/yasubiwemo
Ubushakashatsi bw’ingenzi bwagaragaje ko uburyo CD19 CAR T-selile zavuwe bwagize icyo bugeraho mu kuvura abarwayi bafite leukemia ya lymphoblastic yasubiwemo/yasubiwemo nyuma yo gutera uturemangingo tw’amaraso twa allogeneic hematopoietic, butanga icyizere gishya mu bijyanye n’amaraso.
Bioocus Yateye Imbere Umupaka Mu Kuvura Abana Barwaye Leukemia Ikabije ya Lymphoblastic
Bioocus iri ku isonga mu guteza imbere uburyo bwo kuvura kanseri bw’ikigero gishya. Inyandiko iherutse gusohoka yanditswe na Dr. Chunrong Tong n’ikipe ye mu bitaro bya Lu Daopei igaragaza iterambere rikomeye n’imbogamizi mu ikoreshwa ry’uburyo bwo kuvura kanseri bw’ikigero cya kabiri bwa CD19 ku barwayi b’abana, igaragaza ubwitange bwa Bioocus mu kuvura kanseri mu buryo bushya.